Latest Investments News

Alexium International Group has acquired Microtek Laboratories’ microencapsulation business, marking a strategic pivot to manufacturing-led growth and raising $4.6 million to fund expansion. Despite a slight sales dip, the company is poised for a stronger 2026 with new product lines and military trials underway.

BOA Resources Ltd reported a significant cash flow decline in Q4 2025, with cash reserves dropping sharply. The company plans a capital raise to bolster its financial position and support upcoming exploration activities.

The Star Entertainment Group reported a 6% revenue increase to $301 million and a return to EBITDA profit in Q2 FY26, driven by stable Sydney trading, seasonal Gold Coast strength, and a key Brisbane operator fee. Strategic investments and refinancing efforts mark a pivotal phase for the company.

Cluey Ltd reports a 13% improvement in operating cash outflow and a 0.7% rise in gross profit margin, while preparing to launch its AI-driven Cluey+ platform in February 2026. The company also completed a $4.5 million capital raise and signed an agreement to acquire the Art of Smart group.

Beetaloo Energy Australia Limited reported a solid cash position of $17.96 million at the end of December 2025, supported by $6.8 million in unused financing facilities. The company’s liquidity covers approximately 2.6 quarters of current cash outflows, positioning it well as it awaits the activation of a new $30 million infrastructure facility.

VBX Limited has reported a significant 51% increase in its Wuudagu bauxite resource and enhanced its project feasibility study, supported by fresh funding and robust market conditions.

QPM Energy has secured key contracts and financing milestones for its 112MW Isaac Power Station, while managing stable gas supply amid weak electricity prices.

Viking Mines has entered a binding agreement to acquire six high-grade tungsten projects in Nevada, backed by a strategic investment from American Tungsten Corp and a $4.29 million capital raise. The acquisition marks a significant expansion into the critical US tungsten market amid rising global demand.

Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.

Felix Group Holdings reported a robust 47% increase in total annual recurring revenue for Q2 FY26, driven by the strategic acquisition of Nexvia and expanding enterprise contracts. The company is advancing AI-powered platform enhancements and navigating key leadership transitions.

Celsius Resources has delivered a robust Definitive Feasibility Study for its Maalinao-Caigutan-Biyog Copper-Gold Project, confirming a 35-year mine life and strong economic returns. The company is actively progressing funding arrangements amid growing investor interest.

Holista Colltech has reported a positive operating cash flow for the December quarter, driven by disciplined cost management and a successful capital raise, despite softer sales and ongoing legal disputes.